Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia Disorder
NCT04227587, Not applicable, Completed, The Hong Kong Polytechnic University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia Disorder | ClinicalTrials.gov |
| NCT number | NCT04227587 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 140 participants, actual | ClinicalTrials.gov |
| Lead sponsor | The Hong Kong Polytechnic University | ClinicalTrials.gov |
| Conditions | Insomnia, Primary | ClinicalTrials.gov |
| Interventions | Zero Time Exercise, Sleep hygiene education | ClinicalTrials.gov |
| First posted | 2020-01-13 | ClinicalTrials.gov |
| Last updated | 2023-06-12 | ClinicalTrials.gov |
Registered outcomes 11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in the Insomnia Severity Index score | Baseline, week 8, week 16, week 24 | The subjects rate the severity of insomnia, the distress, and the functional impairment associated with insomnia on a 5-point scale. The score ranges from 0 to 28. The higher the score, the worse the outcome is. | ClinicalTrials.gov |
| Secondary | Sleep diary (7-day) | baseline, week 8, week 16, week 24 | The standardized sleep diary records the daily bedtime and rising time, from which the total time in bed (TIB) can be calculated. | ClinicalTrials.gov |
| Secondary | Hospital Anxiety and Depression Scale | baseline, week 8, week 16, week 24 | The Hospital Anxiety and Depression Scale is a 14-items self-administered questionnaire, which assesses the severity of depressive and anxiety symptoms. The score ranges between 0 and 21 for either anxiety or depression. The higher the score, the worse the outcome is. | ClinicalTrials.gov |
| Secondary | Multidimensional fatigue inventory-20 | baseline, week 8, week 16, week 24 | Multidimensional fatigue inventory-20 is a 20-items self-report instrument designed to measure severity of fatigue. The score ranges from 20 to 100. The higher the score, the worse the outcome is. | ClinicalTrials.gov |
| Secondary | Actigraphy (7-day) | baseline, week 8, week 16, week 24 | Actigraphy measures wrist movements to assess sleep or waking state, is accomplished through an accelerometer in a wrist worn device. | ClinicalTrials.gov |
| Secondary | Accelerometer (7-day) | baseline, week 8, week 16, week 24 | Accelerometer measures wrist movements to assess the physical activity levels. | ClinicalTrials.gov |
| Secondary | Change in WAIS-IV Color Trails Test | baseline, week 8, week 16, week 24 | Change in Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV) Color Trails Test score will be used to measure the attention function. | ClinicalTrials.gov |
| Secondary | Change in WAIS-IV Stroop color-word Test | baseline, week 8, week 16, week 24 | Change in Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV) Stroop color-word Test score will be used to measure the attention function. | ClinicalTrials.gov |
| Secondary | Change in Digit Span-backward test | baseline, week 8, week 16, week 24 | Change in Digit Span-backward and forward test score will be used to measure the memory function. | ClinicalTrials.gov |
| Secondary | Change in the Wisconsin Card Sorting Test | baseline, week 8, week 16, week 24 | Change in the Wisconsin Card Sorting Test score will be used to measure the executive function | ClinicalTrials.gov |
| Other | Intervention adherence (7 day) | week 1-8, week 12-15, week 20-23 | Patients will be told to record their daily physical activities or sleep health hygiene compliance onto the log. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 39999728 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Card Sorting Test (Berg) | Secondary outcome | ConductCognition |
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)